Skip to main content

Nanoviricides, Inc.

NNVC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001379006

No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Nanoviricides, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of NNVC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3229−3
Shares1.21M1.19M−18.9K (−1.6%)
Value$1.24M$1.38M+$148.5K (+12.0%)

New holders (3)

Institutions that held Nanoviricides, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to NNVC in Q1 2024
InstitutionSharesValue% of portfolio
IFP Advisors, Inc1,000$1.16K0.00%
Tower Research Capital LLC (TRC)607$7040.00%
Harbour Investments, Inc.25$290.00%

Sold out (6)

Institutions that held Nanoviricides, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of NNVC in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Virtu Financial LLC16,721$17.0K
Moss Adams Wealth Advisors LLC12,000$12.2K
Game Plan Financial Advisors, LLC450$459
TD Waterhouse Canada Inc.260$365
FMR LLC100$102
Householder Group Estate & Retirement Specialist, LLC150$0